A mathematical model of serotype replacement in pneumococcal carriage following vaccination

Journal of the Royal Society Interface

Volumn 10, Issue 89, 2013, Pages

  Bottomley, Christian ^a   Roca, Anna ^c   Hill, Philip C ^d   Greenwood, Brian ^b   Isham, Valerie ^e  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bacterial carriage; Mathematical model; Pneumococcal vaccine; Serotype replacement

Indexed keywords

MATHEMATICAL MODELS;

BACTERIAL CARRIAGE; CONJUGATE VACCINE; PARAMETER ESTIMATE; SEROTYPES; STREPTOCOCCUS PNEUMONIAE;

VACCINES;

PNEUMOCOCCUS VACCINE; STREPTOCOCCUS VACCINE;

ARTICLE; DISEASE CARRIER; EPIDEMIOLOGICAL DATA; GAMBIA; HUMAN; MATHEMATICAL MODEL; MAXIMUM LIKELIHOOD METHOD; MICROBIAL POPULATION DYNAMICS; PNEUMOCOCCAL INFECTION; PREDICTION; SEROPREVALENCE; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION; BIOLOGICAL MODEL; CLASSIFICATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; PNEUMOCOCCAL INFECTIONS; SEROTYPING; THEORETICAL MODEL; BACTERIAL CARRIAGE; SEROTYPE REPLACEMENT;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

GAMBIA; MODELS, IMMUNOLOGICAL; MODELS, THEORETICAL; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

BACTERIAL CARRIAGE; MATHEMATICAL MODEL; PNEUMOCOCCAL VACCINE; SEROTYPE REPLACEMENT;

EID: 84899770571     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2013.0786     Document Type: Article

References (30)

1. Baltimore RS, Shapiro ED. 1998 Pneumoccal infections. In Bacterial infections of humans: epidemiology and control (eds AS Evans, PS Brachman), pp. 559-582. New York, NY: Plenum Medical Book Company.
2. Obaro SK, Adegbola RA, Banya WA, Greenwood BM. 1996 Carriage of pneumococci after pneumococcal vaccination. Lancet 348, 271-272. (doi:10.1016/S0140-6736(05)65585-7).
3. Pletz MW, Maus U, Krug N, Welte T, Lode H. 2008 Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int. J. Antimicrob. Agents 32, 199-206. (doi:10.1016/j.ijantimicag.2008.01.021).
4. Whitney CG, Moore MR. 2008 Direct and indirect effectiveness and safety of pneumococcal conjugate vaccine in practice. In Pneumococcal vaccines (eds GR Siber, KP Klugman, PH Mäkelä), pp. 353-368. Washington, DC: ASM Press.
5. Weinberger DM, Malley R, Lipsitch M. 2011 Serotype replacement in disease after pneumococcal vaccination. Lancet 378, 1962-1973. (doi:10.1016/S0140- 6736(10)62225-8).
6. Hill PC, Townend J, Antonio M, Akisanya B, Ebruke C, Lahai G, Greenwood BM, Adegbola RA. 2010 Transmission of Streptococcus pneumoniae in rural Gambian villages: a longitudinal study. Clin. Infect. Dis. 50, 1468-1476. (doi:10.1086/652443).
7. Nowak MA, May RM. 1994 Superinfection and the evolution of parasite virulence. Proc. R. Soc. Lond. B 255, 81-89. (doi:10.1098/rspb.1994.0012).
8. Tanaka MM, Feldman MW. 1999 Theoretical considerations of cross-immunity, recombination and the evolution of new parasitic strains. J. Theor. Biol. 198, 145-163. (doi:10.1006/jtbi. 1999.0906). (Pubitemid 29259734)
9. Usuf EA. 2013 The introduction of pneumococcal conjugate vaccine into The Gambia: carriage and costs. PhD thesis, University of London, London, UK.
10. Lipsitch M, Abdullahi O, D'Amour A, Xie W, Weinberger DM, Tchetgen Tchetgen E, Scott JAG. 2012 Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition model. Epidemiology 23, 510-519. (doi:10.1097/EDE. 0b013e31824f2f32).
11. Rinta-Kokko H, Dagan R, Givon-Lavi N, Auranen K. 2009 Estimation of vaccine efficacy against acquisition of pneumococcal carriage. Vaccine 27, 3831-3837. (doi:10.1016/j.vaccine.2009.04.009).
12. Flasche S, Van Hoek AJ, Sheasby E, Waight P, Andrews N, Sheppard C, George R, Miller E. 2011 Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med. 8, e1001017. (doi:10.1371/journal.pmed.1001017).
13. Cheung Y-B, Zaman SMA, Nsekpong ED, Van Beneden CA, Adegbola RA, Greenwood B, Cutts FT. 2009 Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings. Pediatr. Infect. Dis. J. 28, 990-995. (doi:10.1097/INF.0b013e 3181a78185).
14. Roca A et al. 2011 Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in The Gambia: a cluster-randomized trial. PLoS Med. 8, e1001107. (doi:10.1371/journal.pmed.1001107).
15. Egere U, Townend J, Roca A, Akinsanya A, Bojang A, Nsekpong D, Greenwood B, Adegbola RA, Hill PC. 2012 Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trial. PLoS ONE 7, e49143. (doi:10.1371/journal. pone.0049143).
16. Hill PC, Cheung YB, Akisanya A, Sankareh K, Lahai G, Greenwood BM, Adegbola RA. 2008 Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. Clin. Infect. Dis. 46, 807-814. (doi:10.1086/528688). (Pubitemid 351417179)
17. Weinberger DM, Dagan R, Givon-Lavi N, Regev- Yochay G, Malley R, Lipsitch M. 2008 Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage. J. Infect. Dis. 197, 1511-1518. (doi:10.1086/587941). (Pubitemid 351706480)
18. Auranen K, Mehtälä J, Tanskanen A, Kaltoft MS. 2010 Between-strain competition in acquisition and clearance of pneumococcal carriage-epidemiologic evidence from a longitudinal study of day-care children. Am. J. Epidemiol. 171, 169-176. (doi:10.1093/aje/kwp351).
19. Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, O'Brien KL, Pneumococcal Carriage Group. 2012 The fundamental link between pneumococcal carriage and disease. Expert Rev. Vaccines 11, 841-855. (doi:10.1586/erv.12.53).
20. Brueggemann AB, Peto TEA, Crook DW, Butler JC, Kristinsson KG, Spratt BG. 2004 Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J. Infect. Dis. 190, 1203-1211. (doi:10.1086/423820). (Pubitemid 39287745)
21. Adegbola RA, Hill PC, Secka O, Ikumapayi UN, Lahai G, Greenwood BM, Corrah T. 2006 Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003. Trop. Med. Int. Health 11, 1128-1135. (doi:10.1111/j.1365-3156. 2006.01652.x). (Pubitemid 44015251)
22. Goldblatt D et al. 2005 Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J. Infect. Dis. 192, 387-393. (doi:10. 1086/431524). (Pubitemid 41023116)
23. Lipsitch M, Whitney CG, Zell E, Kaijalainen T, Dagan R, Malley R. 2005 Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? PLoS Med. 2, e15. (doi:10.1371/journal.pmed.0020015). (Pubitemid 40412735)
24. Lipsitch M. 1997 Vaccination against colonizing bacteria with multiple serotypes. Proc. Natl Acad. Sci. USA 94, 6571-6576. (doi:10.1073/pnas.94. 12.6571). (Pubitemid 27270726)
25. Melegaro A, Choi YH, George R, Edmunds WJ, Miller E, Gay NJ. 2010 Dynamic models of pneumococcal carriage and the impact of the heptavalent pneumococcal conjugate vaccine on invasive pneumococcal disease. BMC Infect. Dis. 10, 90. (doi:10.1186/1471-2334-10-90).
26. Choi YH, Jit M, Gay N, Andrews N, Waight PA, Melegaro A, George R, Miller E. 2011 7-valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement? PLoS ONE 6, e26190. (doi:10.1371/journal.pone.0026190).
27. Cobey S, Lipsitch M. 2012 Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science 335, 1376-1380. (doi:10.1126/science.1215947).
28. Nurhonen M, Cheng AC, Auranen K. 2013 Pneumococcal transmission and disease in silico: a microsimulation model of the indirect effects of vaccination. PLoS ONE 8, e56079. (doi:10.1371/journal.pone.0056079).
29. Regev-Yochay G, Dagan R, Raz M, Carmeli Y, Shainberg B, Derazne E, Rahav G, Rubinstein E. 2004 Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children. JAMA 292, 716-720. (doi:10.1001/jama.292. 6.716). (Pubitemid 39062526)
30. Cox D, Miller H. 1965 The theory of stochastic processes. Boca Raton, FL: Chapman and Hall. rsif.royalsocietypublishing.org J R Soc Interface 10: 20130786 8.